Hexagons on blue gradient background

AAPS PharmSci 360 2024

Salt Lake City, United States | 21 October 2024 - 24 October 2024
Overview

Join us for AAPS 2024 in Salt Lake City

Quotient Sciences drug development experts will be back for another great year at AAPS PharmSci 360 in Salt Lake City, UT in October. Join us at booth #2419 to discuss your drug development needs and be sure to join us for our various presentation within the AAPS PharmSci conference.    


Attend our conference presentations

Rapid Fire Talk: "Design Space Approach to Optimize Formulation Based on Clinical Data"

Date: Monday October 21, 2024  
Time: 3:00 PM - 3:15 PM 
Presented by: Dr. Vanessa Zann
Room: 255 EF, Salt Palace Convention Center 

Main Stage: "Your hired! Selecting the right pre-IND compound"

Date: Monday October 21, 2024  
Time: 9:00 AM - 10:00 AM
Presented by:
Darren Matthews, Associate Science Director, UK Small Molecule Drug Discovery at Charles River Laboratories
Eleanor Row, VP, Global Commercial Drug Substance at Quotient Sciences
Room: Stage 3, Exhibit Hall 


See our poster presentation

Predicting Belumosudil Drug-Drug Interactions Using a Physiologically Based Pharmacokinetic Model

Presented by: Kevser Sevim, Senior Modelling and Simulation Research Fellow


Join us for our seminar 

RapidFACT® Overcoming the Poor Predictability of Preclinical Models to Accelerate Formulation Optimisation.

Tuesday, October 22

Breakfast & registration beginning at 7:30 AM

Join us during AAPS for our breakfast seminar at the Hyatt on October 22nd.  Vanessa Zann, PhD, Executive Drug Development Consultant will share how Translational Pharmaceutics platform integrates formulation development, on-demand GMP manufacture and clinical testing to accelerate dug development programs.  

Click here to read more and register.  

Advanced registration is required, and spaces are limited!  

Register now
Location
Salt Palace Convention Center
90 S W Temple St
Salt Lake City, United States

Meet our team

Get your drug development questions answered by our experts and network with our extended team. Stop by and speak with our team at the event. 

Eleanor Row, PhD

Executive Director, Candidate Development Scientific Consulting

Eleanor Row has over 15 years of experience in the pharmaceutical and contract research environment working with multinational com...

About Eleanor
Dr. Vanessa Zann

Executive Drug Development Consultant

Dr. Vanessa Zann is an Executive Drug Development Consultant at Quotient Sciences, with over twenty-five years industry experience...

About Vanessa
Dr. Asma Patel

VP, Integrated Development Services

Dr. Asma Patel is VP of Integrated Development Services at Quotient Sciences. In this role, Asma is responsible for providing scie...

About Asma
Mariecris Madayag

Director, Business Development

With an innate passion for medicine, and science, and serving our greater society by driving clinical advancements in the pharmace...

About Mariecris
Liz Dawson

Director, Business Development

Liz Dawson is Director, Business Development with experience in peptide and small molecule API development from concept to clinic....

Contact Us
Jamie Weishaar

Global Commercial Lead, Drug Product

Jamie is an experienced Business Development Executive leader specializing in Pharmaceutical Drug Development, including Contract ...

Contact Us
Drew Lawrence

Business Development Director

Drew is a Business Development Director whose role is to meet and assist drug development customers by completing Phase I clinical...

Contact Us
Jennifer Lattimer

Director, Business Development

Motivated, outgoing and experienced Sales Executive with a demonstrated history of global business closure, B2B selling, cold call...

About Jennifer
Daniel Dennehy

Director Of Business Development

Dan is an accomplished Business Development Director with over 10 years of experience in sales to healthcare, pharmaceutical, and ...

Contact Us

More insight from our experts:

Read More
Translational Pharmaceutics, Clinical Pharmacology, Peptides, Modified Release, Formulation Development, Dr. Andrew Lewis, Dr. Stuart Mair Exploring GLP-1 Agonists: How they work and what the future holds for this promising treatment By: Dr. Andrew Lewis
Learn more
Translational Pharmaceutics, Careers, Miami, Philadelphia, Project Management Colleague Stories: Bethanne Lee
Learn more